Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis

BACKGROUND: Clinical diagnosis and monitoring of Parkinson's disease (PD) remain challenging because of the lack of an established biomarker. Neuromelanin‐magnetic resonance imaging (NM‐MRI) is an emerging biomarker of nigral depigmentation indexing the loss of melanized neurons but has unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Yue, Sapuan, Abdul Halim, Martín‐Bastida, Antonio, Naidu, Saadnah, Tench, Christopher, Evans, Jonathan, Sare, Gillian, Schwarz, Stefan T., Al‐bachari, Sarah, Parkes, Laura M., Kanavou, Sofia, Raw, Jason, Silverdale, Monty, Bajaj, Nin, Pavese, Nicola, Burn, David, Piccini, Paola, Grosset, Donald G., Auer, Dorothee P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303322/
https://www.ncbi.nlm.nih.gov/pubmed/35165920
http://dx.doi.org/10.1002/mds.28934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303322/
https://www.ncbi.nlm.nih.gov/pubmed/35165920
http://dx.doi.org/10.1002/mds.28934

Ejemplares similares